8:05 AM ET
8-K
M&A Deal
SRX Global Signs $10.8M M&A Deal with CERo Therapeutics Holdings, Inc.
SRX Global Inc. entered into a definitive agreement to acquire CERo Therapeutics, Inc. from CERo Therapeutics Holdings, Inc. The total consideration includes $1.0 million in SRX common stock, the cancellation of approximately $8.25 million in outstanding debt under a senior secured promissory note, and the assumption of approximately $1.56 million in liabilities.
- Value
- $10.8M
- Counterparty
- CERo Therapeutics Holdings, Inc.